证券日报网讯 9月5日晚间，建新股份发布公告称，公司近日办理完成了全资子公司沧州建新瑞祥化学 科技有限公司注册资本工商变更登记手续，并取得了中捷产业园区行政审批局换发的《营业执照》。全 资子公司注册资本变更为肆亿捌仟万元整。 （文章来源：证券日报） ...

证券代码：300107 证券简称：建新股份 公告编号：2025-035 河北建新化工股份有限公司 关于全资子公司完成工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载，误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下简称"公司"）于 2025 年 8 月 14 日召开 了第六届董事会第十四次会议，审议通过了《关于对全资子公司增资的议案》。 具体内容详见 2025 年 8 月 16 日披露于巨潮资讯网(www.cninfo.com.cn)的《关 于对全资子公司增资的公告》（公告编号：2025-031）。 公司近日办理完成了全资子公司沧州建新瑞祥化学科技有限公司注册资本 工商变更登记手续，并取得了中捷产业园区行政审批局换发的《营业执照》。具 体情况如下： 注册资本：肆亿捌仟万元整 二、本次变更后的营业执照登记信息 一、本次变更情况 变更前： 注册资本：叁亿伍仟万元整 变更后： 成立日期：2018 年 06 月 13 日 住所：临港化工园区经四路西、纬三路北 1 经营范围：一般项目：第三类非药品类易制毒化学品生产；合成材料制造（不 含危险化学品）；合成材料销售；基础化 ...

Core Points - The company has completed the cancellation of stock options and the expiration of certain restricted stocks as part of its 2022 stock option and restricted stock incentive plan [1] - A total of 1.7165 million stock options granted to 74 incentive recipients were canceled, which had not yet been exercised [1] - The decision was approved by the company's board during its 14th meeting of the 6th session [1] Summary by Sections - **Company Announcement**: The company announced the completion of the cancellation of stock options and the expiration of certain restricted stocks, confirming the accuracy and completeness of the information disclosed [1] - **Details of Cancellation**: The cancellation involved 1.7165 million stock options granted to 74 recipients, which were confirmed by the China Securities Depository and Clearing Corporation [1] - **Completion of Incentive Plan**: Following the cancellation, the implementation of the 2022 stock option and restricted stock incentive plan has been completed [1]

经中国证券登记结算有限责任公司深圳分公司审核确认，公司于 2025 年 8 月 22 日办理完成了 74 名激励对象获授但尚未行权的 171.65 万份股票期权注销 事宜。 证券代码：300107 证券简称：建新股份 公告编号：2025-034 河北建新化工股份有限公司 关于 2022 年股票期权与限制性股票激励计划部分股票期权 注销完成的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下简称"公司"）第六届董事会第十四次会 议审议通过了《关于 2022 年股票期权与限制性股票激励计划部分股票期权注销 及部分限制性股票作废的议案》，决定注销第三个考核期 74 名激励对象已授予的 171.65 万份股票期权。具体内容详见公司 2025 年 8 月 16 日披露于巨潮资讯网 (www.cninfo.com.cn)《关于 2022 年股票期权与限制性股票激励计划部分股票期 权注销以及部分限制性股票作废的公告》（公告编号：2025-032）。 注销完成后，公司 2022 年股票期权与限制性股票激励计划实施完毕。 特此公告。 河北建新化 ...

Group 1 - The latest stock price of Jianxin Co. is 8.20 yuan, up 1.11% from the previous trading day, with a trading volume of 116 million yuan [1] - Jianxin Co. operates in the chemical products industry, with main products including dyes, daily chemical intermediates, pharmaceutical and pesticide intermediates, paper chemicals, composite materials, and new material intermediates [1] - In the first half of 2025, Jianxin Co. reported total revenue of 238 million yuan, a year-on-year decrease of 25.98%, and a net profit attributable to shareholders of 5.377 million yuan, down 54.98% year-on-year [1] Group 2 - The company indicated that weak downstream demand and intensified industry competition led to a decline in product prices, while fluctuations in raw material costs also impacted performance [1] - Additionally, exchange rate fluctuations and changes in overseas market policies posed challenges to the company's export business [1] - On August 18, Jianxin Co. experienced a net outflow of main funds amounting to 6.1304 million yuan, with a cumulative net outflow of 22.5609 million yuan over the past five days [2]

Group 1 - The core viewpoint of the articles indicates that Jianxin Co., Ltd. (300107) has reported a significant decline in both revenue and net profit for the first half of 2025, with total revenue of 238 million yuan, down 25.98% year-on-year, and a net profit attributable to shareholders of 5.377 million yuan, down 54.98% year-on-year [1][2] - In Q2 2025, the company generated a revenue of 120 million yuan, reflecting a year-on-year decrease of 28.34%, while the net profit for the same period was 3.7668 million yuan, a slight decline of 1.25% [1] - The company's accounts receivable are notably high, with accounts receivable amounting to 317.83% of the latest annual net profit, indicating potential liquidity issues [1][2] Group 2 - The gross margin for the reporting period was 8.93%, down 30.69% year-on-year, and the net margin was 2.26%, down 39.17% year-on-year, suggesting a decline in profitability [1] - Total selling, administrative, and financial expenses amounted to 5.8236 million yuan, accounting for 2.45% of revenue, which is a decrease of 7.13% year-on-year [1] - The company's return on invested capital (ROIC) was reported at 0.4% last year, with a historical median ROIC of 2.22% over the past decade, indicating weak investment returns [2]

Core Viewpoint - Jianxin Co., Ltd. (300107.SZ) reported its semi-annual results for 2025, indicating a modest increase in institutional ownership and foreign investment in its A-shares [1] Institutional Ownership - As of August 15, 2025, there are 2 institutional investors holding a total of 4.3132 million shares of Jianxin, representing 0.77% of the total share capital [1] - The institutional ownership increased by 0.31 percentage points compared to the previous quarter [1] Foreign Investment - One foreign fund, Hong Kong Central Clearing Limited, increased its holdings during this period, contributing to a 0.31% rise in foreign ownership [1]

Group 1 - The core point of the article is that Jianxin Co., Ltd. plans to invest 130 million RMB in its wholly-owned subsidiary, Cangzhou Jianxin Ruixiang Chemical Technology Co., Ltd., to enhance its business operations and competitiveness [1] - In 2024, Jianxin Co., Ltd.'s revenue composition is projected to be 99.9% from the fine chemical industry and 0.1% from other businesses [1] - The current market capitalization of Jianxin Co., Ltd. is 4.6 billion RMB [2]

Group 1 - The core viewpoint of the article highlights the significant decline in the financial performance of Jianxin Co., Ltd. for the first half of 2025, with a notable drop in both revenue and net profit [2] Group 2 - Jianxin Co., Ltd. reported an operating income of approximately 238 million yuan for the first half of 2025, representing a year-on-year decrease of 25.98% [2] - The net profit attributable to shareholders of the listed company was approximately 5.38 million yuan, reflecting a year-on-year decline of 54.98% [2] - The basic earnings per share were reported at 0.0096 yuan, which is a decrease of 55.35% compared to the previous year [2]

Core Viewpoint - The company plans to invest RMB 130 million in its wholly-owned subsidiary, Cangzhou Jianxin Ruixiang Chemical Technology Co., Ltd., to enhance its business operations and competitiveness, aligning with project construction and strategic development needs [1] Group 1 - The investment amount is RMB 130 million [1] - The investment aims to expand the business of Hebei Jianxin Chemical Co., Ltd. [1] - The funding will be sourced from the company's own funds [1]